News Release - November 12, 2007

Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients

Source: Abbott

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.